Navigation Links
NIDA supports development of combined anti-heroin and HIV vaccine
Date:7/25/2012

Dr. Gary R. Matyas has been selected the 2012 recipient of the NIDA Avant-Garde Award for Medications Development. Matyas proposes to develop an effective, safe and easily manufactured combination anti-heroin/HIV vaccine that could treat heroin addiction while at the same time prevent HIV infection in those receiving the vaccine. Matyas will receive $1,000,000 per year for five years to support his research. He works at the Walter Reed Army Institute of Research (WRAIR) in Silver Spring, M.d. The National Institute on Drug Abuse (NIDA), part of the National Institutes of Health, announced the award today.

"This highly innovative dual-vaccine model would simultaneously address the intertwined epidemics of heroin abuse and HIV," said NIDA Director Dr. Nora D. Volkow. "This is precisely the type of ground-breaking research NIDA's Avant-Garde program was designed to support. The implications for public health are enormous."

The proposal stems from an existing research collaboration between NIDA and the U.S. Military HIV Research Program, part of the WRAIR. In 2010, the two organizations entered into an agreement to create a combination anti-heroin/HIV vaccine. The goal was to build upon previous preclinical research indicating that hapten-based anti-drug vaccinesin which a small molecule chemically similar to a drug of abuse (hapten) is bound to a protein carrier to induce an immune responseshowed promise against a variety of abused drugs, including heroin. As a result of this collaboration, the heroin component of a combination anti-heroin/HIV vaccine has now been created and is ready for optimization and advanced preclinical testing.

This current grant award will support this next phase of research and development. The award will be administered through the Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. and work done in collaboration with the U.S. Military HIV Research Program and NIDA.

"Heroin use is strongly associated with a high risk of HIV infection and represents an increasingly important worldwide health problem," stated Matyas. "The possibility of creating a combination heroin-HIV vaccine provides an important opportunity to address both a unique treatment for heroin abuse as well as continuing the quest to develop an effective preventive HIV vaccine."


'/>"/>

Contact: NIDA Press Team
media@nida.nih.gov
301-443-6245
NIH/National Institute on Drug Abuse
Source:Eurekalert  

Related medicine news :

1. Study Supports Value of Sigmoidoscopy, an Alternative to Colonoscopy
2. Study supports urate protection against Parkinsons disease, hints at novel mechanism
3. Dietary fiber alters gut bacteria, supports gastrointestinal health
4. Narconon Louisiana Supports United Nations International Day Against Drug Abuse and Illicit Trafficking
5. 2 genetic deletions in human genome linked to the development of aggressive prostate cancer
6. Kudos for 3 NJIT Enterprise Development Center high-tech companies
7. 2 repressor genes identified as essential for placental development
8. Louisiana Tech University professor earns NSF Early Career Development grant
9. Advanced genetic screening method may speed vaccine development
10. New biospecimens management system in development
11. Developmental Woes Common in Siblings of Children With Autism
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
NIDA supports development of combined anti-heroin and HIV vaccine
(Date:5/2/2016)... , ... May 02, 2016 , ... ... in Huntington Beach, California announced today the release of Grow Healthy Vending’s newly ... is one of the fastest growing healthy vending providers in North America with ...
(Date:5/2/2016)... ... ... This week Omega Institute, a premier nonprofit educational retreat center in New York’s ... offering a record 370 in-person workshops and new online learning opportunities and live ... or need for the knowledge and skills we’ve been cultivating for nearly 40 years. ...
(Date:5/2/2016)... ... 02, 2016 , ... The 2016 World Ultimate & Guts Championship (WUGC) Mixed roster was announced ... the cut. The WUGC is being held in London, England this year from June 18-25. ... men’s division, another gold in the women’s masters division, and a silver in the women’s ...
(Date:5/2/2016)... ... May 02, 2016 , ... TeleMedCo™, ... facilities designed to automate and improve the rapid diagnosis, triage and admission of ... their platform, application, and mobile experience for the first time at GENBAND’s Perspectives16 ...
(Date:5/2/2016)... (PRWEB) , ... May 02, 2016 , ... ... improve adherence, transition of care and quality outcomes, has announced its partnership with ... innovative, independent pharmacy that provides over the counter and prescription drug pharmacy services ...
Breaking Medicine News(10 mins):
(Date:5/2/2016)... 2, 2016 The global  ... 11.1 billion by 2024, according to a new ... drivers of the sonography market include expanding applications ... recommendations for periodic ultrasound screenings of the breast ... http://photos.prnewswire.com/prnh/20150105/723757 ) High Intensity Focused ...
(Date:4/29/2016)... PARIS , April 29, 2016 ... Jérôme Contamine, Directeur Financier ... la santé, publie ses résultats pour ... Financier du Groupe, Jérôme Contamine, commente ... Groupe et les perspectives pour le ...
(Date:4/28/2016)... , April 28, 2016  While Abbott,s ... complement the company,s valve repair and stent business, ... also places Abbott more firmly into patient monitoring.  ... the fastest growing device areas, with double-digit growth ... recent report,  Advanced Remote Patient Monitoring ...
Breaking Medicine Technology: